Session Details

[27-12-am]Inflammation and immune system

Thu. Mar 27, 2025 8:30 AM - 10:06 AM JST
Thu. Mar 27, 2025 11:30 PM - 1:06 AM UTC
Room 12 (Fukuoka International Congress Center: 414 [4F])
Chair: Masashi Tachibana, Hiroya Ohta

[27-12-am01S]Exploration of Adjuvants to Enhance the Efficacy of mRNA Cancer Vaccine

○Haruki Hirata1,2, Toshiro Hirai1,2,3,4, Yasuo Yoshioka1,2,3,4,5,6,7 (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. RIMD, Osaka Univ., 3. OTRI, Osaka Univ., 4. CAMaD, Osaka Univ., 5. MEI, Osaka Univ., 6. CiDER, Osaka Univ., 7. BIKEN)

[27-12-am02S]Adenosine suppresses expression of adhesion molecules in vascular endothelial cells

○Haruto Yamawaki1, Yurino Kai2, Michiko Yoshii1, Yuki Yanase1, Koichiro Ozawa1 (1. Grad. Sch. Biomedical and Health Sciences, Hiroshima Univ., 2. Fac. Pharm. Sci., Hiroshima Univ.)

[27-12-am03S]Mechanisms of dendritic cells activation by honeydew honey

○Riko Takane1, Cheolwoo Mo1, Hikaru Aoshima1, Yu Matsushita1, Mirika Sugiyama1, Yoshihiro Okamoto1 (1. Faculty of Pharmacy, Chiba Institute of Science)

[27-12-am04S]KIRA6 suppresses antigen-induced mast cells and basophils activation

○goshi matsushima1, Yuri Matsui2, Hanano Okamoto2, Nagisa Umeda2, Tadashi Nakagawa3, Kaori Ishii1, Yoshimi Matsuo1, Daiki Matsubara1, Akio Tanaka1, Michiko Yoshii1, Yuhki Yanase1, Toru Hosoi3, Koichiro Ozawa1 (1. Graduate School of Biomedical and Health Sciences, Hiroshima University, 2. School of Pharmaceutical Sciences, Hiroshima University,, 3. Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University)

[27-12-am05S]Effects of SMTP-44D on diabetic retinopathy in vivo and in vitro models

○Mio Ishibashi1,2, Keita Shibata1,2, Michishige Terasaki3, Yuta Saito3, Sho-ichi Yamagishi3, Keiji Hasumi4,5, Koji Nobe1,2 (1. Showa Univ. Grad. Sch. Pharm., 2. Showa Univ. Pharmacol. Res. Cet., 3. Showa Univ. Grad. Sch. Med., 4. Tokyo Univ. Agric. & Technol. Grad. Sch. Agric., 5. TMS Co., Ltd.)

[27-12-am06]Anti-human TLR7 antibody for therapeutic intervention in systemic lupus erythematosus

○Yusuke Murakami1,2,6, Ryutaro Fukui2, Atsuo Kanno2, Yuji Motoi2, Atsushi Manno3, Tomohiro Honda3, Shinnosuke Yamada3, Jun Ishiguro3, Takashi Kagari3, Kensuke Nakamura3, Michinori Kadokura3, Takashi Isobe3, Yoshiaki Tomimori4, Jun Tanaka3, Senaldi Giorgio 4, Toshiaki Shimizu5, Kensuke Miyake2 (1. Faculty of Pharmacy, Musashino University, 2. Division of Innate Immunity, The Institute of Medical Science, The University of Tokyo, 3. Daiichi Sankyo Co., Ltd., 4. Daiichi Sankyo, Inc., 5. Graduate School of Pharmaceutical Sciences, The University of Tokyo, 6. Institute of Pharmacy, Musashino University)

[27-12-am07]Application of Cannabinoid as Novel Adjuvant to Influenza Vaccine.

○Takuma Gotanda1, Ryotarou Mitsumata1 (1. Denka Vaccine Research)

[27-12-am08]Effect of a cyclin-dependent kinase 4/6 inhibitor on development of lung fibrosis in severe asthma model of mice

○MASAYA MATSUDA1, Emi Ishizu1, Yuna Fujiwara1, Hayato Shimora1, Takeshi Nabe1 (1. Setsunan Univ.)